These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 9581698
1. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Gane EJ, Lo SK, Riordan SM, Portmann BC, Lau JY, Naoumov NV, Williams R. Hepatology; 1998 May; 27(5):1403-7. PubMed ID: 9581698 [Abstract] [Full Text] [Related]
2. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO. Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984 [Abstract] [Full Text] [Related]
3. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, Trepo C. Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166 [Abstract] [Full Text] [Related]
4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Clin Transplant; 2006 Aug; 20(6):677-83. PubMed ID: 17100715 [Abstract] [Full Text] [Related]
5. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover. Zeuzem S, Schmidt JM, Lee JH, von Wagner M, Teuber G, Roth WK. Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119 [Abstract] [Full Text] [Related]
6. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [Abstract] [Full Text] [Related]
7. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation. Giostra E, Kullak-Ublick GA, Keller W, Fried R, Vanlemmens C, Kraehenbuhl S, Locher S, Egger HP, Clavien PA, Hadengue A, Mentha G, Morel P, Negro F. Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764 [Abstract] [Full Text] [Related]
8. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J. Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337 [Abstract] [Full Text] [Related]
9. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up. Angelico M, Gandin C, Pescarmona E, Rapicetta M, Del Vecchio C, Bini A, Spada E, Baroni CD, Capocaccia L. Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298 [Abstract] [Full Text] [Related]
10. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience. Burra P, Targhetta S, Pevere S, Boninsegna S, Guido M, Canova D, Brolese A, Masier A, D'Aloiso C, Germani G, Tomat S, Fagiuoli S. Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285 [Abstract] [Full Text] [Related]
11. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA. Transplant Proc; 2004 May; 36(6):1831-4. PubMed ID: 15350490 [Abstract] [Full Text] [Related]
12. Therapy of hepatitis C: alpha interferon and ribavirin. Reichard O, Schvarcz R, Weiland O. Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674 [Abstract] [Full Text] [Related]
13. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ. Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988 [Abstract] [Full Text] [Related]
14. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, Saracco G. Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995 [Abstract] [Full Text] [Related]
15. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Jain AB, Eghtesad B, Venkataramanan R, Fontes PA, Kashyap R, Dvorchik I, Shakil AO, Kingery L, Fung JJ. Liver Transpl; 2002 Nov; 8(11):1007-13. PubMed ID: 12424713 [Abstract] [Full Text] [Related]
16. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta. Asahina Y, Izumi N, Uchihara M, Noguchi O, Tsuchiya K, Hamano K, Kanazawa N, Itakura J, Miyake S, Sakai T. Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623 [Abstract] [Full Text] [Related]
17. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin. Bizollon T, Ducerf C, Trépo C. J Hepatol; 1995 Aug; 23 Suppl 2():22-5. PubMed ID: 8720290 [Abstract] [Full Text] [Related]
18. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Féray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynès M, Bismuth H. Hepatology; 1995 Oct; 22(4 Pt 1):1084-9. PubMed ID: 7557855 [Abstract] [Full Text] [Related]
19. Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha. Hassan Q, Roche B, Buffet C, Bessede T, Samuel D, Charpentier B, Durrbach A. Transpl Int; 2012 Sep; 25(9):941-7. PubMed ID: 22882335 [Abstract] [Full Text] [Related]
20. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Gopal DV, Rabkin JM, Berk BS, Corless CL, Chou S, Olyaei A, Orloff SL, Rosen HR. Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158 [Abstract] [Full Text] [Related] Page: [Next] [New Search]